EKF — EKF Diagnostics Holdings Share Price
Last trade - 00:00- £107.73m
- £94.50m
- £51.56m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.63 | ||
| PEG Ratio (f) | 0.3 | ||
| EPS Growth (f) | 92.96% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.56 | ||
| Price to Tang. Book | 2.62 | ||
| Price to Free Cashflow | 14.68 | ||
| Price to Sales | 2.09 | ||
| EV to EBITDA | 7.64 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.47% | ||
| Return on Equity | 3% | ||
| Operating Margin | 13.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 81.84 | 66.64 | 52.61 | 50.19 | 51.56 | 54.62 | 58.38 | -4.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +58.06 | -91.95 | +227.3 | +54.5 | -66.83 | +246.93 | +11.76 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EKF Diagnostics Holdings plc is a United Kingdom-based global diagnostics company. The Company's business is focused on point-of-care and life sciences. The Company's point-of-care analyzers are utilized worldwide, with patients benefiting from receiving rapid medical advice and diagnosis. The Company produces and distributes point-of-care medical devices and in-vitro diagnostic (IVD) tests for use at or near the patient’s location, allowing healthcare professionals to make decisions. Its point-of-care products include hemoglobin products and diabetes products. The Company's life sciences services provide specialist manufacturing of enzymes and custom products for use in diagnostic, food and industrial applications. The Company's solutions include precision fermentation, bio-processing, diagnostic enzymes, and contract reagent formulation and kitting. It develops and provides a range of devices, tests, and media for analysis in central laboratory settings.
Directors
- Christopher Mills NEC (69)
- David Salter CEO
- Julian Baines VCH (56)
- Marc Davies CFO
- Christian Rigg NED
- Jennifer Winter NED
- Carl Contadini NID (72)
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- January 7th, 2002
- Public Since
- June 5th, 2002
- No. of Employees
- 301
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 430,903,112
- Address
- Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ
- Web
- https://www.ekfdiagnostics.com/
- Phone
- +44 2920710570
- Auditors
- PricewaterhouseCoopers LLP
Latest News for EKF
Upcoming Events for EKF
EKF Diagnostics Holdings PLC Annual Shareholders Meeting
EKF Diagnostics Holdings PLC Annual Shareholders Meeting
Half Year 2026 EKF Diagnostics Holdings PLC Earnings Release
Similar to EKF
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
Cambridge Nutritional Sciences
London Stock Exchange
FAQ
As of Today at 20:24 UTC, shares in EKF Diagnostics Holdings are trading at 25.00p. This share price information is delayed by 15 minutes.
Shares in EKF Diagnostics Holdings last closed at 25.00p and the price had moved by +13.64% over the past 365 days. In terms of relative price strength the EKF Diagnostics Holdings share price has underperformed the FTSE All Share Index by -4.19% over the past year.
The overall consensus recommendation for EKF Diagnostics Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreEKF Diagnostics Holdings does not currently pay a dividend.
EKF Diagnostics Holdings does not currently pay a dividend.
EKF Diagnostics Holdings does not currently pay a dividend.
To buy shares in EKF Diagnostics Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 25.00p, shares in EKF Diagnostics Holdings had a market capitalisation of £107.73m.
Here are the trading details for EKF Diagnostics Holdings:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: EKF
Based on an overall assessment of its quality, value and momentum EKF Diagnostics Holdings is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in EKF Diagnostics Holdings is 34.67p. That is 38.68% above the last closing price of 25.00p.
Analysts covering EKF Diagnostics Holdings currently have a consensus Earnings Per Share (EPS) forecast of £0.02 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EKF Diagnostics Holdings. Over the past six months, its share price has underperformed the FTSE All Share Index by -4.7%.
As of the last closing price of 25.00p, shares in EKF Diagnostics Holdings were trading -5.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EKF Diagnostics Holdings PE ratio based on its reported earnings over the past 12 months is 14.63. The shares last closed at 25.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
EKF Diagnostics Holdings' management team is headed by:
- Christopher Mills - NEC
- David Salter - CEO
- Julian Baines - VCH
- Marc Davies - CFO
- Christian Rigg - NED
- Jennifer Winter - NED
- Carl Contadini - NID